Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 05 2023
Historique:
received: 17 11 2022
accepted: 02 05 2023
medline: 26 5 2023
pubmed: 25 5 2023
entrez: 24 5 2023
Statut: epublish

Résumé

The association between long-term exposure to ambient air pollutants and severe COVID-19 is uncertain. We followed 4,660,502 adults from the general population in 2020 in Catalonia, Spain. Cox proportional models were fit to evaluate the association between annual averages of PM

Identifiants

pubmed: 37225741
doi: 10.1038/s41467-023-38469-7
pii: 10.1038/s41467-023-38469-7
pmc: PMC10209206
doi:

Substances chimiques

Nitrogen Dioxide S7G510RUBH
Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2916

Informations de copyright

© 2023. The Author(s).

Références

Chest. 2019 Feb;155(2):409-416
pubmed: 30419235
BMC Med Res Methodol. 2018 Oct 29;18(1):118
pubmed: 30373524
Int J Epidemiol. 2023 Feb 8;52(1):44-57
pubmed: 36474414
Euro Surveill. 2021 Mar;26(9):
pubmed: 33663646
Environ Int. 2021 Sep;154:106564
pubmed: 33964723
EBioMedicine. 2022 Nov;85:104291
pubmed: 36183487
Environ Health Perspect. 2020 Sep;128(9):95001
pubmed: 32902328
Am J Respir Crit Care Med. 2023 Jan 15;207(2):218-221
pubmed: 36125979
Am J Respir Crit Care Med. 2022 Aug 15;206(4):440-448
pubmed: 35537137
BMC Public Health. 2021 Sep 3;21(1):1612
pubmed: 34479535
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Environ Int. 2022 Jan;158:106930
pubmed: 34678637
Eur Respir Rev. 2021 Feb 9;30(159):
pubmed: 33568525
Eur Respir J. 2022 Jul 26;:
pubmed: 35896215
Am J Epidemiol. 2022 Jan 24;191(2):282-286
pubmed: 34613347
BMC Med Res Methodol. 2022 Aug 4;22(1):211
pubmed: 35927612
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Environ Pollut. 2022 Sep 1;308:119686
pubmed: 35779662
Environ Int. 2022 Mar;161:107147
pubmed: 35180670
Respir Med. 2021 Mar;178:106313
pubmed: 33550152
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
Environ Res. 2021 Apr;195:110722
pubmed: 33422505
Environ Int. 2018 Nov;120:81-92
pubmed: 30075373
Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148655
Am J Epidemiol. 2009 Jul 15;170(2):244-56
pubmed: 19494242
Environ Adv. 2022 Oct;9:100270
pubmed: 35912397
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
BMC Fam Pract. 2020 Feb 17;21(1):39
pubmed: 32066377
BMJ. 2014 Aug 21;349:g5060
pubmed: 25146097
CMAJ. 2022 May 24;194(20):E693-E700
pubmed: 35609912
Am J Epidemiol. 2021 Jul 1;190(7):1396-1405
pubmed: 33576387
Nat Commun. 2021 Feb 3;12(1):777
pubmed: 33536436
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1429-1439
pubmed: 35258439
Am J Respir Crit Care Med. 2022 Mar 15;205(6):651-662
pubmed: 34881681
Environ Health Perspect. 2021 Nov;129(11):117003
pubmed: 34787480

Auteurs

Otavio Ranzani (O)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Anna Alari (A)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Sergio Olmos (S)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Carles Milà (C)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Alex Rico (A)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Joan Ballester (J)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.

Xavier Basagaña (X)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Carlos Chaccour (C)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universidad de Navarra, Pamplona, Spain.
CIBER Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Payam Dadvand (P)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Talita Duarte-Salles (T)

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.

Maria Foraster (M)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
PHAGEX Research Group, Blanquerna School of Health Science, Universitat Ramon Llull (URL), Barcelona, Spain.

Mark Nieuwenhuijsen (M)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Jordi Sunyer (J)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Antònia Valentín (A)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Manolis Kogevinas (M)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Uxue Lazcano (U)

Instituto Biodonostia, Grupo Atención Primaria, San Sebastian, Spain.
Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain.

Carla Avellaneda-Gómez (C)

Complex Hospitalari Moisès Broggi, Consorci Sanitari Integral, Barcelona, Spain.

Rosa Vivanco (R)

Agency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain.

Cathryn Tonne (C)

Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain. cathryn.tonne@isglobal.org.
Universitat Pompeu Fabra (UPF), Barcelona, Spain. cathryn.tonne@isglobal.org.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. cathryn.tonne@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH